US Markets for Varicose Vein Treatment Devices 2007

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US VARICOSE VEIN TREATMENT DEVICE MARKET

• 1.1 Disease Overview
• 1.2 Market Overview
• 1.3 Market Analysis
  • 1.3.1 Procedures
  • 1.3.2 Market Forecast
  • 1.3.3 Market Drivers and Limiters
• 1.4 Competitive Analysis

2.0 ENDOVENOUS ABLATION DEVICE MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Procedures
    • 2.2.1.1 Endovenous Laser Ablation
    • 2.2.1.2 Endovenous Radiofrequency Ablation
  • 2.2.2 Market Forecast
    • 2.2.2.1 Endovenous Laser Ablation
    • 2.2.2.2 Endovenous Radiofrequency Ablation
  • 2.2.3 Market Drivers and Limiters
  • 2.2.4 In the News
• 2.3 Competitive Analysis

3.0 SURGICAL STRIPPING DEVICE MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Procedures
  • 3.2.2 Market Forecast
  • 3.2.3 Market Drivers and Limiters
• 3.3 Competitive Analysis

4.0 PHLEBECTOMY DEVICE MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Procedures
  • 4.2.2 Market Forecast
  • 4.2.3 Market Drivers and Limiters
• 4.3 Competitive Analysis

5.0 SCLEROTHERAPY MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Procedures
    • 5.2.1.1 Varicose Vein Sclerotherapy
    • 5.2.1.2 Spider Vein Sclerotherapy
  • 5.2.2 Market Forecast
    • 5.2.2.1 Varicose Vein Sclerotherapy
    • 5.2.2.2 Spider Vein Sclerotherapy
  • 5.2.3 Market Drivers and Limiters
• 5.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: Varicose Vein Treatment Device Market, US (US$), 2005-2011
• Exhibit 2: Endovenous Ablation Procedures, by Type, US, 2005-2011
• Exhibit 3: Surgical Stripping Procedures, US, 2005-2011
• Exhibit 4: TIPP Market, US (US$), 2005-2011
• Exhibit 5: Sclerotherapy Market, US (US$), 2005-2011
• Exhibit 6: Leading Competitors in the Varicose Vein Treatment Device Market, as a % of Total, US, 2006

CHAPTER 1: US VARICOSE VEIN TREATMENT DEVICE MARKET

• Exhibit 7: Risk Factors for Developing Varicose Veins
• Exhibit 8: Varicose Vein Prevalence, Diagnosis, and Treatment, US, 2005-2011
• Exhibit 9: Varicose Vein Treatment Device Market, US (US$), 2005-2011
• Exhibit 10: Varicose Vein Procedures, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 11: Varicose Vein Procedures, by Type, US, 2005-2011 (Tabular Format)
• Exhibit 12: GSV and Large Truncal Vein Procedures, by Type, US, 2006 and 2011
• Exhibit 13: Perforator Vein Procedures, by Type, US, 2006 and 2011
• Exhibit 14: Varicose Vein Treatment Device Market, by Type, US (US$), 2005-2011 (Graphical Format)
• Exhibit 15: Varicose Vein Treatment Device Market, by Type. US (US$), 2005-2011 (Tabular Format)
• Exhibit 16: Drivers of the Varicose Vein Treatment Device Market, US
• Exhibit 17: Limiters of the Varicose Vein Treatment Device Market, US
• Exhibit 18: Leading Competitors in the Varicose Vein Treatment Device Market, as a % of Total, US, 2006
• Exhibit 19: Leading Competitors in the Varicose Vein Treatment Device Market, by Type, as a % of Total, US, 2006

CHAPTER 2: ENDOVENOUS ABLATION DEVICE MARKET

• Exhibit 20: Endovenous Ablation Device Market, US (US$), 2005-2011
• Exhibit 21: Comparison of ELA and ERFA Procedures
• Exhibit 22: Endovenous Ablation Procedures, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 23: Endovenous Ablation Procedures, by Type, US, 2005-2011 (Tabular Format)
• Exhibit 24: Endovenous Ablation Device Market, by Type, US (US$), 2005-2011 (Graphical Format)
• Exhibit 25: Endovenous Ablation Device Market, by Type, US (US$), 2005-2011 (Tabular Format)
• Exhibit 26: ELA Market, US (US$), 2005-2011
• Exhibit 27: ELA Market, by Segment, US (US$), 2005-2011
• Exhibit 28: ERFA Market, US (US$), 2005-2011
• Exhibit 29: ERFA Market, by Segment, US (US$), 2005-2011
• Exhibit 30: Drivers of the Endovenous Ablation Device Market, US
• Exhibit 31: Limiters of the Endovenous Ablation Device Market, US
• Exhibit 32: Endovenous Ablation Patent Litigation Timeline, US, 2003-2007
• Exhibit 33: Endovenous Ablation Patent Litigation Timeline, US, 2003-2007
• Exhibit 34: Leading Competitors in the Endovenous Ablation Device Market, as a % of Total, US, 2006
• Exhibit 35: Leading Competitors in the ELA Market, as a % of Total, US, 2006
• Exhibit 36: Available Products in the Endovenous Ablation Market, US, 2007
• Exhibit 37: Available Products in the Endovenous Ablation Market, US, 2007

CHAPTER 3: SURGICAL STRIPPING DEVICE MARKET

• Exhibit 38: Surgical Stripping Device Market, US (US$), 2005-2011 (Graphical Format)
• Exhibit 39: Surgical Stripping Procedures, US, 2005-2011 (Graphical Format)
• Exhibit 40: Surgical Stripping Procedures, US, 2005-2011 (Tabular Format)
• Exhibit 41: Surgical Stripping Device Market, US (US$), 2005-2011 (Tabular Format)
• Exhibit 42: Drivers of the Surgical Stripping Device Market, US
• Exhibit 43: Limiters of the Surgical Stripping Device Market, US
• Exhibit 44: Leading Competitors in the Surgical Stripping Device Market, as a % of Total, US, 2006

CHAPTER 4: PHLEBECTOMY DEVICE MARKET

• Exhibit 45: TIPP Market, US (US$), 2005-2011 (Graphical Format)
• Exhibit 46: Phlebectomy Procedures, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 47: Phlebectomy Procedures, by Type, US, 2005-2011 (Tabular Format)
• Exhibit 48: TIPP Market, US (US$), 2005-2011 (Tabular Format)
• Exhibit 49: Drivers of the Phlebectomy Device Market, US
• Exhibit 50: Limiters of the Phlebectomy Device Market, US

CHAPTER 5: SCLEROTHERAPY DEVICE MARKET

• Exhibit 51: Sclerotherapy Market, US (US$), 2005-2011
• Exhibit 52: Sclerotherapy Procedures, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 53: Sclerotherapy Procedures, by Type, US, 2005-2011 (Tabular Format)
• Exhibit 54: Varicose Vein Sclerotherapy Procedures, US, 2005-2011 (Tabular Format)
• Exhibit 55: Varicose Vein Sclerotherapy Procedures, US, 2005-2011 (Graphical Format)
• Exhibit 56: Spider Vein Sclerotherapy Procedures, US, 2005-2011
• Exhibit 57: Sclerotherapy Market, by Type, US (US$), 2005-2011 (Graphical Format)
• Exhibit 58: Sclerotherapy Market, by Type, US (US$), 2005-2011 (Tabular Format)
• Exhibit 59: Varicose Vein Sclerotherapy Market, US (US$), 2005-2011
• Exhibit 60: Spider Vein Sclerotherapy Market, US (US$), 2005-2011
• Exhibit 61: Drivers of the Sclerotherapy Market, US
• Exhibit 62: Limiters of the Sclerotherapy Market, US
• Exhibit 63: Leading Competitors in the Sclerotherapy Market, as a % of Total, US, 2006